Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 181
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

    The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals. A...

    Thermal and Fluid Dynamical Effects on the Efficiency of Hyperpolarized Xenon Production

    The American Lung Association estimates that 32 million Americans are affected by lung diseases, many of which...

    Backer Badge Funded